By Stephanie Uses, PharmD, MJ, JD (Patient Safety Analyst, ECRI Institute), Lynn Razzano, RN, MSN, ONCC (Clinical Nurse Consultant, Physician-Patient Alliance for Health & Safety), and Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)
Inadequate monitoring for respiratory depression in patients receiving opioids poses the greatest risk and potentially resulting harm to patients. ECRI Institute recently released the 2016 Top 10 Patient Safety Concerns for Healthcare Organizations and assigned inadequate monitoring its highest risk map of 80:
To read the article, please click here.